About the Company
We do not have any company description for PharmaCyte Biotech, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”) announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors ...
PharmaCyte Biotech Secures $7 Million Private Placement
PharmaCyte Biotech ( ($PMCB) ) has issued an update. On August 17, 2025, PharmaCyte Biotech, Inc. announced a $7 million private placement ...
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s ...
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (“Femasy ...
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A ...
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 million investment in MyMD Pharmaceuticals, Inc. (Nasdaq:MYMD) (“MyMD”) a clinical stage ...
PharmaCyte Biotech Launches Malignant Ascites Program with ... - Nasdaq
PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ...
PMCB - PharmaCyte Biotech Inc Key Metrics | Morningstar
Review the current PharmaCyte Biotech Inc (PMCB:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if PMCB is the best investment for you.
PharmaCyte Biotech Reports Positive Interim Results in ... - Nasdaq
PharmaCyte Biotech, Inc., a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology, Cell ...
PharmaCyte Biotech, Inc. net worth, bio and insider trades.
Who is PharmaCyte Biotech, Inc.? PharmaCyte Biotech, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares in FEMASYS INC.
EFY - PharmaCyte Biotech Inc Key Metrics | Morningstar
Review the current PharmaCyte Biotech Inc (EFY:XMUN) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if EFY is the best investment for you.
Similar Companies
Loading the latest forecasts...